This is a competitive renewal for years 32 to 36 of the Interdisciplinary Postdoctoral Training Program in Drug Abuse Research at Mount Sinai. We seek to vigorously train a highly talented diverse group of postdoctoral researchers to integrate basic and translational research in the pharmacology, physiology and neurobiology of drug abuse. The program has a long and distinguished history and our past trainees have compiled a gratifying record of achievements. The program has been reconfigured to provide interdisciplinary training that maintains Sinai's historical strengths and takes advantage of new intellectual, educational, programmatic and physical resources of the school. Under the leadership of Dean Dennis Charney, Mount Sinai over the past decade has recruited a highly renowned broad-based faculty in drug abuse research such as L. A. Devi (Director of this training program), Y. Hurd (Co-Director of this program), E. Nestler and most recently Paul Slesinger. Dr. Nestler is the director of the Friedman Brain Research Institute and the chairman of the Department of Neuroscience. He has embarked on a collaborative program with the Dr. Wayne Goodman, Chairman of the Department of Psychiatry to further develop live imaging modalities in substance abuse research. The postdoctoral training program will train inter- and trans-disciplinary researchers who can go to develop independent and collaborative research programs that significantly advance the basic understanding and treatment of this important social and medical problem. The training program encourages participation of faculty mentors whose research grants specifically target drug abuse, as well as those whose research is critically important for the interdisciplinary training we seek to impart;thus offering fellows flexibility in developing truly interdisciplinary research projects between laboratories. The training will have a didactic component to foster quantitative reasoning skills as well as training to understand and maintain awareness of the ethical issues in research. The trainees will be provided with dynamic guidance to develop independent research projects that can serve as the basis to launch successful independent careers in substance abuse research. Mount Sinai provides a fertile environment and significant resources for this important training program that will contribute robustly to the national pipeline of highly trained interdisciplinary investigators working on drug abuse research problem.

Public Health Relevance

We describe a postdoctoral training program that reflects an interdisciplinary vision that will train researchers who can significant advance the basic understanding and treatment of drug addiction that is an important social and medical problem. This training program also offer fellows flexibility in obtaining basic, translational and clinical training in drug abuse research.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Babecki, Beth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Johnston, Jennifer M; Filizola, Marta (2014) Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. PLoS One 9:e90694
Gupta, Achla; Gomes, Ivone; Wardman, Jonathan et al. (2014) Opioid receptor function is regulated by post-endocytic peptide processing. J Biol Chem 289:19613-26
Toniolo, Elaine F; Maique, Estêfani T; Ferreira Jr, Wilson A et al. (2014) Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides 56:125-31
Michaelides, Michael; Miller, Michael L; Subrize, Mike et al. (2013) Limbic activation to novel versus familiar food cues predicts food preference and alcohol intake. Brain Res 1512:37-44
Jacobs, Michelle M; Murray, Jacinta; Byrd, Desiree A et al. (2013) HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations. J Neurovirol 19:495-504
Sillivan, Stephanie E; Whittard, John D; Jacobs, Michelle M et al. (2013) ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry 74:511-9
Taubenfeld, Stephen M; Muravieva, Elizaveta V; Garcia-Osta, Ana et al. (2010) Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner. Proc Natl Acad Sci U S A 107:12345-50
Lobo, Mary Kay; Covington 3rd, Herbert E; Chaudhury, Dipesh et al. (2010) Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330:385-90
Abul-Husn, Noura S; Bushlin, Ittai; Moron, Jose A et al. (2009) Systems approach to explore components and interactions in the presynapse. Proteomics 9:3303-15
Gonzalez-Maeso, Javier; Ang, Rosalind L; Yuen, Tony et al. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93-7

Showing the most recent 10 out of 68 publications